CIK 0000882796 · Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 621413174
- Phone
- 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-12 | LEVIN ALAN G Director | Grant or award · Automatic Stock Option Grant | +27,181 | 27,181 | ||
| 2025-06-12 | Hutson Nancy J Director | Grant or award | +12,500 | 99,138 | ||
| 2025-06-12 | Hutson Nancy J Director | Grant or award · Automatic Stock Option Grant | +27,181 | 27,181 | ||
| 2025-06-12 | HEGGIE THERESA Director | Grant or award | +12,500 | 65,352 | ||
| 2025-06-12 | HEGGIE THERESA Director | Grant or award · Automatic Stock Option Grant | +27,181 | 27,181 | ||
| 2025-06-12 | Galson Steven K Director | Grant or award | +12,500 | 24,991 | ||
| 2025-06-12 | Galson Steven K Director | Grant or award · Automatic Stock Option Grant | +27,181 | 27,181 | ||
| 2025-06-12 | Frank Steven Director | Grant or award | +12,500 | 14,699 | ||
| 2025-06-12 | Frank Steven Director | Grant or award · Automatic Stock Option Grant | +27,181 | 27,181 | ||
| 2025-05-30 | MILANO VINCENT Director | Grant or award | +523 | $10.75 | $6K | 77,260 |
| 2025-05-30 | Frank Steven Director | Grant or award | +333 | $10.75 | $4K | 2,199 |
| 2025-05-02 | Frank Steven Director | Grant or award | +1,866 | 1,866 | ||
| 2025-05-02 | Frank Steven Director | Grant or award · Automatic Stock Option Grant | +4,079 | 4,079 | ||
| 2025-03-31 | Thackray Helen M. Chief R&D Officer | Shares withheld for taxes | −7,525 | $7.50 | $56K | 377,318 |
| 2025-02-28 | MILANO VINCENT Director | Grant or award | +653 | $8.61 | $6K | 76,737 |
| 2024-12-20 | Stonehouse Jon P President & CEO | Gift | −20,000 | 1,429,109 | ||
| 2024-12-20 | Stonehouse Jon P President & CEO | Gift | +10,000 | 30,000 | ||
| 2024-12-20 | Stonehouse Jon P President & CEO | Gift | +10,000 | 30,000 | ||
| 2024-12-19 | Gayer Charles K Chief Commercial Officer | Grant or award | +125,950 | 426,007 | ||
| 2024-12-19 | Gayer Charles K Chief Commercial Officer | Shares withheld for taxes | −2,461 | $7.39 | $18K | 423,546 |
Page 6 of 18 · 357 trades